Compare GRFS & VSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | VSAT |
|---|---|---|
| Founded | 1940 | 1986 |
| Country | Spain | United States |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.6B |
| IPO Year | N/A | 1996 |
| Metric | GRFS | VSAT |
|---|---|---|
| Price | $7.84 | $46.17 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 6 |
| Target Price | $10.15 | ★ $43.60 |
| AVG Volume (30 Days) | 682.6K | ★ 1.2M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 1.79% | N/A |
| EPS Growth | N/A | ★ 50.88 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.33 | $5.34 |
| Revenue Next Year | $6.50 | $3.59 |
| P/E Ratio | $18.67 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.19 | $7.36 |
| 52 Week High | $11.14 | $50.24 |
| Indicator | GRFS | VSAT |
|---|---|---|
| Relative Strength Index (RSI) | 27.72 | 51.43 |
| Support Level | $7.64 | $41.76 |
| Resistance Level | $9.11 | $49.81 |
| Average True Range (ATR) | 0.29 | 2.88 |
| MACD | -0.12 | -0.24 |
| Stochastic Oscillator | 2.99 | 40.24 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Viasat Inc provides bandwidth technologies and services in three segments: communication services and defense and advanced technologies. The communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers: and the defense and advanced technologies segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging core technical competencies in encryption, cyber security, tactical gateways, modems and waveforms. A large majority of the firm's revenue is generated from communication services segment.